At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
3.0 T Neonatal MRI scannerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
In Brief
A clinical study evaluating 3.0 T Neonatal MRI scanner for Neonatal Neuroimaging. Completed, enrolled 54 participants across 1 site.
Detailed Summary
This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for imaging viable neonate and infant populations. This MR system has a smaller size and design features that may make it more feasible to locate the system in close proximity to care areas for neonates (birth - 1 month) and infants (\>1 month to two years), such as clinical neonatal intensive care units (NICUs) and other infant and neonatal care departments.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeonatal Neuroimaging
CountriesUnited Kingdom
CollaboratorsWellcome Trust
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedMay 2016
Primary CompletionAug 2017
Study CompletionApr 2018
TodayJul 2026
First PostedMay 30, 2016
Enrollment StartMar 22, 2016
Primary CompletionAug 20, 2017
Study CompletionApr 20, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.1 years ago
Interventions
3.0 T Neonatal MRI scannerdevice
eligible subjects will undergo neonatal MRI scan procedure